Among the 68 fatal cases, 36 patients (53%) died of respiratory failure, five patients (7%) with myocardial damage died of circulatory failure, 22 patients (33%) died of both, and five remaining died of an unknown cause.

University of Michigan - Ann Arbor

Classification of COVID-19 Studies on Fatality in China

Fatality of COVID-19 in Asia by Country

Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020). Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive care medicine, 46(5), 846–848. https://doi.org/10.1007/s00134-020-05991-x

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Of the 68 patients that had died from COVID-19, 11 patients (16%) had a secondary infection (Wuhan, China).

Mortality in Secondary COVID-19 Infection in Wuhan, China

The distribution of survival time from disease onset to death showed two peaks, with the first one at approximately 14 days (22 cases) and the second one at approximately 22 days (17 cases).

Survival Times of Patients with COVID-19 in Wuhan, China

Cause of Death in COVID-19 Patients in Wuhan, China

As of March 3, 2020, a study of 150 COVID-19-infected patients found a morbidity: 19% (p-value<0.001)

Cardiovascular Disease in COVID-19 Patients in Wuhan, China: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Learn Before

Related